期刊
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
卷 23, 期 20, 页码 -出版社
MDPI
DOI: 10.3390/ijms232012609
关键词
epigenetics; DNA methylation; histone modifications; microRNA; prion diseases; prion-like diseases
资金
- Gobierno de Aragon
- European Social Fund [IIU/2023/2017]
- MINECO [AGL2015-67945-P]
- FEDER 2014-2020 Construyendo Europa desde Aragon
- European Regional Development Fund (ERDF)
- Gobierno de Aragon [A19-20R]
Prion diseases and prion-like diseases involve protein misfolding and aggregation, with the potential involvement of epigenetic mechanisms in the pathology of these diseases. These findings could be important clues for disease pathology research and biomarker development.
Prion diseases are transmissible spongiform encephalopathies (TSEs) caused by a conformational conversion of the native cellular prion protein (PrP (c)) to an abnormal, infectious isoform called PrPSc. Amyotrophic lateral sclerosis, Alzheimer's, Parkinson's, and Huntington's diseases are also known as prion-like diseases because they share common features with prion diseases, including protein misfolding and aggregation, as well as the spread of these misfolded proteins into different brain regions. Increasing evidence proposes the involvement of epigenetic mechanisms, namely DNA methylation, post-translational modifications of histones, and microRNA-mediated post-transcriptional gene regulation in the pathogenesis of prion-like diseases. Little is known about the role of epigenetic modifications in prion diseases, but recent findings also point to a potential regulatory role of epigenetic mechanisms in the pathology of these diseases. This review highlights recent findings on epigenetic modifications in TSEs and prion-like diseases and discusses the potential role of such mechanisms in disease pathology and their use as potential biomarkers.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据